Literature DB >> 24708134

The mitochondrial DNA 10197 G > A mutation causes MELAS/Leigh overlap syndrome presenting with acute auditory agnosia.

Yinglin Leng1, Yuhe Liu, Xiaojing Fang, Yao Li, Lei Yu, Yun Yuan, Zhaoxia Wang.   

Abstract

Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes/Leigh (MELAS/LS) overlap syndrome is a mitochondrial disorder subtype with clinical and magnetic resonance imaging (MRI) features that are characteristic of both MELAS and Leigh syndrome (LS). Here, we report an MELAS/LS case presenting with cortical deafness and seizures. Cranial MRI revealed multiple lesions involving bilateral temporal lobes, the basal ganglia and the brainstem, which conformed to neuroimaging features of both MELAS and LS. Whole mitochondrial DNA (mtDNA) sequencing and PCR-RFLP revealed a de novo heteroplasmic m.10197 G > A mutation in the NADH dehydrogenase subunit 3 gene (ND3), which was predicted to cause an alanine to threonine substitution at amino acid 47. Although the mtDNA m.10197 G > A mutation has been reported in association with LS, Leber hereditary optic neuropathy and dystonia, it has never been linked with MELAS/LS overlap syndrome. Our patient therefore expands the phenotypic spectrum of the mtDNA m.10197 G > A mutation.

Entities:  

Keywords:  Cortical deafness; NADH dehydrogenase subunit 3 gene; mitochondrial disorders

Mesh:

Substances:

Year:  2014        PMID: 24708134     DOI: 10.3109/19401736.2014.905860

Source DB:  PubMed          Journal:  Mitochondrial DNA        ISSN: 1940-1736


  10 in total

1.  Revisiting germinal vesicle transfer as a treatment for aneuploidy in infertile women with diminished ovarian reserve.

Authors:  John Zhang
Journal:  J Assist Reprod Genet       Date:  2014-12-18       Impact factor: 3.412

2.  Extended spinal cord involvement in adult-onset Leigh syndrome due to mitochondrial 10197G > A mutation.

Authors:  Yanping Wei; Min Qian; Yingmai Yang
Journal:  Neurol Sci       Date:  2022-07-31       Impact factor: 3.830

3.  Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes/Leigh Overlap Syndrome Due to Variant m.13513G>A in MT-ND5.

Authors:  Josef Finsterer; John Hayman
Journal:  Cureus       Date:  2022-05-05

Review 4.  The genetics of Leigh syndrome and its implications for clinical practice and risk management.

Authors:  Ilene S Ruhoy; Russell P Saneto
Journal:  Appl Clin Genet       Date:  2014-11-13

5.  Visual and neurologic sequelae of methanol poisoning in Saudi Arabia.

Authors:  Alberto Galvez-Ruiz; Sahar M Elkhamary; Nasira Asghar; Thomas M Bosley
Journal:  Saudi Med J       Date:  2015-05       Impact factor: 1.484

6.  Generating Rho-0 Cells Using Mesenchymal Stem Cell Lines.

Authors:  Mercedes Fernández-Moreno; Tamara Hermida-Gómez; M Esther Gallardo; Andrea Dalmao-Fernández; Ignacio Rego-Pérez; Rafael Garesse; Francisco J Blanco
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

7.  Novel and recurrent nuclear gene variations in a cohort of Chinese progressive external ophthalmoplegia patients with multiple mtDNA deletions.

Authors:  Yue Hou; Xutong Zhao; Zhiying Xie; Meng Yu; He Lv; Wei Zhang; Yun Yuan; Zhaoxia Wang
Journal:  Mol Genet Genomic Med       Date:  2022-03-15       Impact factor: 2.473

8.  Leigh Syndrome in Childhood: Neurologic Progression and Functional Outcome.

Authors:  Jin Sook Lee; Hunmin Kim; Byung Chan Lim; Hee Hwang; Jieun Choi; Ki Joong Kim; Yong Seung Hwang; Jong Hee Chae
Journal:  J Clin Neurol       Date:  2016-04       Impact factor: 3.077

9.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

Review 10.  Mitochondrial diseases caused by mtDNA mutations: a mini-review.

Authors:  Anastasia I Ryzhkova; Margarita A Sazonova; Vasily V Sinyov; Elena V Galitsyna; Mariya M Chicheva; Alexandra A Melnichenko; Andrey V Grechko; Anton Yu Postnov; Alexander N Orekhov; Tatiana P Shkurat
Journal:  Ther Clin Risk Manag       Date:  2018-10-09       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.